A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
BioNTech SE
BioNTech SE
University of Alabama at Birmingham
Genmab
Parabilis Medicines, Inc.
National Institutes of Health Clinical Center (CC)
Eikon Therapeutics
Genmab
Alliance Foundation Trials, LLC.
858 Therapeutics, Inc.
Radiopharm Theranostics, Ltd